510(k) Report

FDA applicant

W. L. Gore and Associates, Inc.

Flagstaff, AZ4 decisions2018–20221 recall

FDA records 4 decisions for W. L. Gore and Associates, Inc. (Flagstaff, AZ) from 2018 to 2022: 3 510(k) clearances and 1 original PMA approval. Most are in product codes MJN (Catheter, Intravascular Occluding, Temporary) and DQY (Catheter, Percutaneous). Its devices cite 4 predicates, 0 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, cardiovascular panel, where it files most

How often FDA has decided W. L. Gore and Associates, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2022

2018: 22020: 12022: 1
2018high 2 (2018) · low 0 (2019)2026

2026 so far, outlined.

Recalls per year

1in 2021

2021: 1
2018high 1 (2021) · low 0 (2018)2026

Class I Class II/III not classified

FIG. 1 — W. L. Gore and Associates, Inc. by year, 2018–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like W. L. Gore and Associates, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report